ANDA 75145, held by Lannett Co Inc. Selegiline Hydrochloride.
As of Nov 15, 2026, ANDA 75145 (Selegiline Hydrochloride), held by Lannett Co Inc, was first approved by FDA on Sep 15, 2003, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 15, 2003 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Selegiline Hydrochloride5MG ยท capsule;oral | Selegiline Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
